Document is current
Any future updates will be listed below
-
Authors
Wanke, Carsten https://orcid.org/0000-0001-5861-1726
Pinkert, Joerg
Geworski, Lilli
Szermerski, Bastian
-
Funding
Funding for this research was provided by:
Medizinische Hochschule Hannover (MHH)
- License Information
-
More Information
Article History
Received: 16 May 2024
Accepted: 13 January 2025
First Online: 23 January 2025
Declarations
:
: The measurements have been performed in the context of the study “RAPSODY - Measurement of radiation exposure of relatives and caregivers during outpatient therapy with Ra-223 dichloride in Germany”, which had been conducted as a substudy to the international early access program for Radium-223 dichloride (study 16216), a formal phase IIIb study. The study has been approved by the ethics commission of the Landesamt für Gesundheit und Soziales (Regional Office for Health and Social Affairs) Berlin, Germany, and all subjects signed an informed consent form.
: Carsten Wanke, Bastian Szermerski and Lilli Geworski received consulting fees from Bayer Vital GmbH. Jörg Pinkert is employed by Bayer AG and holds stocks of Bayer AG. No other potential conflicts of interest relevant to this article exist.
